HEAL Initiative: Career Development Awards in Implementation Science for Substance Use Prevention and Treatment (K01 - Clinical Trial Required)
ID: 342406Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Award Range

$0 - $275K

Eligible Applicants

Others

Funding Category

Health

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/342406

Additional Information

http://grants.nih.gov/grants/guide/pa-files/PAS-22-206.html
Timeline
    Description

    The National Institutes of Health (NIH) has announced the HEAL Initiative: Career Development Awards in Implementation Science for Substance Use Prevention and Treatment (K01), aimed at supporting early career researchers in addiction science. This grant provides an opportunity for eligible applicants to develop expertise in implementation science methods while conducting research projects that align with the HHS Overdose Prevention Strategy, focusing on areas such as opioid use disorder treatment and harm reduction. The initiative is critical in addressing the ongoing opioid crisis by fostering a new generation of researchers capable of translating evidence-based practices into effective community interventions. Interested applicants can apply for funding up to $275,000, with a closing date for submissions set for November 12, 2025. For further inquiries, applicants may contact the NIH OER Webmaster at OERWebmaster03@od.nih.gov or visit the additional information link at http://grants.nih.gov/grants/guide/pa-files/PAS-22-206.html.

    Point(s) of Contact
    OERWebmaster03@od.nih.gov
    Files
    Title
    Posted
    PAS-22-206-Full-Announcement.html
    PAS-22-206.html
    The Department of Health and Human Services, particularly through the NIH, has issued a Funding Opportunity Announcement (FOA) for the HEAL Initiative, aimed at supporting early career investigators in implementing science research focused on substance use prevention and treatment. The K01 Research Scientist Development Award offers up to five years of funding, enabling awardees to lead independent clinical trials aligned with the HHS Overdose Prevention Strategy. The program addresses the urgent need for researchers equipped to translate evidence-based practices into viable community interventions, particularly amidst the opioid crisis. Eligible applicants, including individuals with foundational training in addiction research, must demonstrate a commitment to developing a sustained research career. Each application must articulate clear career development activities, mentoring plans, and research strategies aimed at integrating substance use treatment with co-occurring mental health or social conditions. The application process involves stringent criteria, emphasizing diversity in research teams and ethical considerations in research practices. This FOA highlights the NIH's commitment to bolster the scientific workforce capable of tackling America's addiction crises through targeted research.
    Similar Opportunities
    HEAL Initiative: Career Development Awards in Implementation Science for Substance Use Prevention and Treatment (K23 - Clinical Trial Required)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a grant opportunity titled the HEAL Initiative: Career Development Awards in Implementation Science for Substance Use Prevention and Treatment (K23), aimed at supporting early career researchers and clinicians in the field of addiction. Applicants are required to have clinical training and must propose an independent clinical trial that aligns with the HHS Overdose Prevention Strategy, focusing on areas such as opioid misuse prevention, treatment, harm reduction, and recovery support services. This initiative is crucial for addressing the ongoing substance use crisis by fostering a new generation of implementation researchers who can effectively translate research into clinical practice. Interested applicants can find more information and apply by November 12, 2025, with funding support of up to $100,000 per year for salary and additional research costs. For inquiries, contact the NIH OER Webmaster at OERWebmaster03@od.nih.gov or visit the opportunity's webpage at http://grants.nih.gov/grants/guide/pa-files/PAS-22-207.html.
    HEAL Initiative: Translating Research to Practice to End the Overdose Crisis (R33 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity titled "HEAL Initiative: Translating Research to Practice to End the Overdose Crisis," aimed at supporting research that translates findings into practical solutions for addressing the overdose crisis. This initiative encourages applications from a diverse range of organizations, including educational institutions and nonprofits, with a focus on developing stigma-free, patient-centered systems for addiction recovery and improving the quality of addiction treatment services. The NIH plans to commit approximately $10 million to fund grants, with an expected award ceiling of $750,000 for up to 12 awards, and applications will be accepted starting February 20, 2025, with a closing date of March 20, 2025. For further inquiries, interested parties can contact NIH Grants Information at grantsinfo@nih.gov or visit the opportunity's webpage at https://grants.nih.gov/grants/guide/rfa-files/RFA-DA-25-077.html.
    HEAL Initiative: Translating Research to Practice to End the Overdose Crisis (R61/R33 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is inviting applications for the HEAL Initiative funding opportunity titled "Translating Research to Practice to End the Overdose Crisis" (RFA-DA-23-053). This initiative aims to support research that translates findings into actionable practices to combat the ongoing overdose crisis in the U.S., with a focus on developing innovative, scalable, and equitable strategies for patient-centered care in addiction treatment. The funding mechanism allows for projects to span up to six years, divided into a two-year planning phase (R61) and a five-year implementation phase (R33), with an anticipated total funding of up to $15 million based on the quality of applications received. Interested applicants can find more details and submission guidelines at the provided link and should direct inquiries to the NIH OER Webmaster at OERWebmaster03@od.nih.gov. The application deadline is March 20, 2025.
    HEAL Initiative: Translating Research to Practice to End the Overdose Crisis (R61/R33 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "HEAL Initiative: Translating Research to Practice to End the Overdose Crisis" (RFA-DA-25-078), aimed at supporting research that transforms addiction treatment and care to combat the ongoing overdose crisis. This initiative encourages phased applications (R61/R33), where the R61 phase focuses on exploratory activities without the need for existing pilot data, while the R33 phase seeks to implement larger studies based on successful R61 milestones, emphasizing stigma-free and patient-centered approaches. With up to $10 million allocated for FY2026 and a maximum award period of six years, applicants must include a Plan for Enhancing Diverse Perspectives (PEDP) to ensure inclusivity, and applications are to be submitted through Grants.gov by the closing date of March 20, 2025. For further inquiries, interested parties can contact NIH Grants Information at grantsinfo@nih.gov.
    HEAL Initiative: Translating Research to Practice to End the Overdose Crisis (R33 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "HEAL Initiative: Translating Research to Practice to End the Overdose Crisis" (RFA-DA-23-054), aimed at supporting innovative research that bridges the gap between research findings and practical applications to combat the opioid overdose crisis. This initiative emphasizes the need for stigma-free, patient-centered care systems and focuses on understudied areas related to overdose prevention, requiring applicants to present preliminary data for significant projects within a maximum project period of five years and a budget of up to $750,000 in direct costs annually. The funding reflects a commitment to addressing health disparities and promoting effective addiction treatment and recovery solutions, with applications evaluated based on significance, innovation, feasibility, and stakeholder engagement. Interested applicants should note that the application deadline is March 20, 2025, and can direct inquiries to the NIH OER Webmaster at OERWebmaster03@od.nih.gov.
    HEAL Initiative: Research to Increase Implementation of Substance Use Preventive Services (R01 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a federal grant opportunity under the HEAL Initiative, aimed at enhancing the implementation and sustainability of substance use preventive services. This initiative seeks to address the critical gaps between effective prevention research and its practical application, particularly in combating the opioid crisis, by soliciting applications for projects that demonstrate preliminary data and focus on strengthening prevention infrastructure. With approximately $4.65 million available for funding, grants can support projects for up to five years, with annual budget requests advised to remain under $800,000. Interested applicants must submit their proposals by January 16, 2026, and can find additional information and guidelines at the NIH grants website or contact NIH Grants Information at grantsinfo@nih.gov.
    HEAL Initiative: Research to Increase Implementation of Substance Use Preventive Services (R61/R33 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity under the HEAL Initiative aimed at enhancing the implementation of preventive services for substance use disorders, specifically focusing on opioid misuse. This initiative invites applications for research that addresses gaps in the dissemination and implementation of prevention services, with a phased R61/R33 award mechanism allowing for up to six years of support, contingent on the successful completion of preliminary milestones. The overarching goal is to establish a sustainable prevention infrastructure that effectively reduces risks associated with substance use, emphasizing equity and community involvement in the research process. Interested applicants can find more information and apply by the deadline of January 16, 2026, with a projected funding amount of $4.65 million for the 2024 fiscal year. For inquiries, contact NIH Grants Information at grantsinfo@nih.gov or visit the opportunity's webpage at https://grants.nih.gov/grants/guide/rfa-files/RFA-DA-24-066.html.
    HEAL Initiative Advanced Postdoctoral-to-Independent Career Transition Award in PAIN and SUD Research (Independent Basic Experimental Studies with Humans Required)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced the HEAL Initiative Advanced Postdoctoral-to-Independent Career Transition Award, aimed at supporting researchers in the fields of pain and substance use disorder (SUD). This grant program, known as the K99/R00 Career Transition Award, is designed to facilitate the transition of outstanding postdoctoral researchers into independent investigator roles, with a focus on conducting basic experimental studies involving human participants. The initiative is part of NIH's broader strategy to address the opioid epidemic by enhancing research on alternative pain treatments and improving addiction treatment strategies. Interested applicants must be in postdoctoral positions with no more than four years of experience, and the application deadline is March 11, 2025. For further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov.
    HEAL Initiative Advanced Postdoctoral-to-Independent Career Transition Award in PAIN and SUD Research (K99/R00 Independent Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the HEAL Initiative Advanced Postdoctoral-to-Independent Career Transition Award (K99/R00) to support postdoctoral researchers transitioning to independent careers in Pain and Substance Use Disorder (SUD) research. This grant program aims to enhance the independent investigator workforce by providing up to five years of funding, divided into a mentored phase lasting up to two years and an independent phase lasting up to three years, specifically designed to address the critical need for innovative solutions in pain management and addiction treatment amid the ongoing opioid crisis. Eligible applicants must be in mentored postdoctoral positions and are encouraged to propose rigorous biomedical research plans, although independent clinical trials are not permitted. Interested candidates should submit their proposals by March 11, 2025, and can find additional information and application guidelines at the NIH grants website or contact NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    HEAL Initiative Advanced Postdoctoral-to-Independent Career Transition Award in PAIN and SUD Research to Promote Diversity (K99/R00 Independent Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced the HEAL Initiative Advanced Postdoctoral-to-Independent Career Transition Award (K99/R00), aimed at promoting diversity in research related to Pain and Substance Use Disorders (SUD). This funding opportunity is designed to support newly trained independent investigators from diverse backgrounds, facilitating their transition from postdoctoral positions to independent faculty roles, with the K99 phase offering up to two years of mentored research training and the R00 phase providing up to three years of independent research support for those who secure tenure-track positions. This initiative is part of a broader response to the national opioid crisis, addressing the critical need to increase diverse professionals in biomedical research. Interested applicants must have less than four years of postdoctoral experience and demonstrate a commitment to research relevant to NIH's goals. The application deadline is March 11, 2025, and further details can be obtained by contacting NIH Grants Information at grantsinfo@nih.gov or visiting the official announcement at https://grants.nih.gov/grants/guide/rfa-files/RFA-NS-22-025.html.